BKYI
Bio-key International·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 0
High Gross Profit Margin
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BKYI
Bio-Key International, Inc.
A provider of Identity Access Management (IAM) and Biometric Cybersecurity Solutions
101 CRAWFORDS CORNER ROAD, SUITE 4116, HOLMDEL, NJ 07733
--
Bio-key International, Inc., founded in Delaware in 1993 to develop and market advanced fingerprint biometric technology and provide related security software solutions, was originally established as BBG Engineering Corporation, renamed SAC Technology Corporation in 1994 and BIO-key International, Inc., in 2002, The company develops and sells advanced fingerprint biometric identification and identity verification technology, as well as provides related identity management, authentication hardware and software solutions, and is a pioneer in developing automation, finger recognition technology, and providing other identification and verification methods such as personal identification, passwords, tokens, smart cards, ID cards, PKIs, credit cards, passports, driving licenses, OTP or other possessed or knowledge-based forms of authentication. In addition, advanced BIO-key technology has been used and used to improve the accuracy and speed of finger biometrics, the most differentiated and effective commercially available finger biometrics have been developed, the main focus is to market and sell this technology to obtain business logic and physical privileges to gain market share. Its main market focus includes enterprise security, mobile payments and authentication, healthcare records and data security, among others. The second focus includes the government market, large-scale identity verification programs such as voter registration, driver's licenses, national ID and SIM card registration.
Earnings Call
Q3/2025
Estimate EPS-0.12
Actual EPS-0.15
Estimate Revenue1.80M
Actual Revenue1.55M
BIO-Key's Q3 2025: Contradictions Emerge on Revenue Growth, Operating Expenses, Expansion, Bank of Egypt Deployment, and ARR Expectations
Nov 14,2025 02:40
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BKYI has released its 2025 Q3 earnings. EPS was reported at -0.15, versus the expected -0.12, missing expectations. The chart below visualizes how BKYI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BKYI has released its 2025 Q3 earnings report, with revenue of 1.55M, reflecting a YoY change of -27.75%, and net profit of -964.85K, showing a YoY change of -30.57%. The Sankey diagram below clearly presents BKYI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
